Cervical Cancer Clinical Trial
Official title:
A Community-based Health Intervention Trial to Increase Attendance to Cervical Cancer-screening Program Among Immigrants in Norway.
Although health-related interventions should become increasingly diversity-sensitive, there
will always be a need of adapting specific interventions to some immigrant populations.
Adapting selected services to the individual cultural and religious background is necessary
to reduce health inequalities and provide effective health care and is dependent on the
active involvement of users. In this proposal the investigators present a community-based
health intervention trial with two parallel interventions aimed at increasing participation
of immigrant women to the existing cervical cancer-screening program. Through this study, the
investigators will provide new practice-based knowledge and a firmer evidence base to improve
health interventions that can contribute to equal health care and good health for all -
including the immigrant population.
Based on identified barriers and factors that influence the interactions between immigrants
and health care professionals for screening of cervical cancer in Norway, the investigators
have develop two adapted interventions. One strategy will target immigrant women, and the
other one will focus on general practitioners. Thus, this proposal will specifically
contribute to the development of personalized health prevention interventions for the most
common cancer-screening program in Norway, with a focus on immigrant's personal circumstances
and health care needs.
Goals and objectives of the project The present study is designed to evaluate the
effectiveness of two different community-based strategies to increase the attendance to the
cervical cancer screening prevention program. Interventions have been developed together with
stakeholders and conducted in two different geographical areas in Norway. Each intervention
group will be compared to a control population in the same county in the first place. The
main outcome to compare will be the percentage of women in each group attending to the
screening program. However, the investigators will not only focus on this quantitative
outcome, but also on the underlying processes determining how communities and individuals
change their behaviour.
Secondly, the effect of the interventions measured quantitatively will be compared to each
other in order to be able to prioritise one of the two strategies if needed, although
strategies will probably be complementary. A particular interest of the interventions is to
examine whether and how immigrant women respond to different intervention strategies.
Methods This study is designed as a community-based health intervention trial. A key feature
of such trials is the allocation of intact communities or clusters of individuals rather than
individuals themselves to different intervention groups.
The study will rely on both quantitative and qualitative evaluation of the interventions. For
the quantitative part,each of the two interventions will be compared to its control. In
addition, the effects of the interventions will be compared. Additionally, to know how the
interventions increased (or not) attendance to the screening program post-intervention focus
groups among intervention subjects will be conducted.
Interventions, participants and participating areas Two different intervention strategies
have developed, one of them meant to increase awareness and attendance among users, and the
other one targeting health professionals.
1. User intervention Area and design The developed User intervention will be implemented in
the counties of Akershus and Buskerud. Women from Somalia and Pakistan were chosen as
targets for this intervention after previous analyses for register data. Sample size was
calculated for an increase in cancer screening participation from 0.45 to 0.55 with 80%
power and 5% significance level. The investigators tried several intra class correlation
(ICC) levels, and ended dividing the area in 16 clusters that were matched according to
the calculated number of female immigrants aged 20 to 66 from Somalia and Pakistan.
After assuring that pairs were not naturally linked by a mosque or other natural known
gather centre for these populations, clusters were randomly assigned to intervention or
control groups.
Participants All women from Somalia and Pakistan living in the intervention clusters
compose the intervention groups; immigrant women from the same countries of origin
living in control clusters will be control participants. It is estimated that 625 and
915 women in screening age from Somalia and Pakistan respectively live in the study area
(Akershus and Buskerud). Approximately half part of the women from each country will be
in the intervention clusters.
Intervention Bilingual key women from the two chosen countries were recruited and
trained as peer educators for their respective communities to increase awareness
regarding the importance of cervical cancer prevention and to help peers overcome
detected barriers and increase attendance to screening. The strategy to achieve these
goals relied upon meetings with the women organised according to their practical needs,
using videos and other interactive materials.
2. Heath professional intervention Area The developed Heath professional intervention will
be implemented in Bergen. Sample size was calculated for an increase in cancer screening
participation for non-Western immigrants (all groups together) from 0.45 to 0.55 with
80% power and 5% significance level. The investigators tried several intra class
correlation (ICC) levels, and finally divided the area in 20 clusters that were matched
according to the cluster size and the calculated number of female non-Western immigrants
aged 20 to 66. The clusters were thereafter randomly assigned to intervention or control
groups.
Participants All General practitioners working in the intervention cluster areas were
assigned to the intervention group; similarly, health professionals working in the other
clusters will be chosen as controls. Women will for the analyses be linked to their
general practitioner through the General Practice Database.
Intervention Based on the existing evidence and on interviews conducted with health
professionals, an appropriate intervention was developed to increase awareness of the
health professionals involved in screening working in the chosen areas. Health
professionals in the intervention areas will be contacted by letter and a personal
appointment was made to explain the intervention. No change in "screening as usual" will
be implemented for health professionals working in the control areas.
3. Post-intervention qualitative studies Among participants included in the intervention
areas, focus groups/in depth-interviews will be conducted right after the interventions
are implemented among both users and health professionals to understand whether and how
each of the interventions worked.
Measurements The study relies on both quantitative and qualitative evaluation of the
interventions.
1. Outcome information on screening attendance for intervention and control groups will be
obtained from the Norwegian Cytology registry, where all pap smears taken in Norway are
registered. The leader of the Norwegian Cytology register is part of the Reference group
for this study, and this register can provide data for the variables Morphology (if the
test is taken, if it is normal or pathological) and date for test for all women in
Norway after the necessary permissions are given. This register will be then linked at
the individual level to the Norwegian National Registry in order to obtain information
regarding immigrant background, country of origin as explained below, reason for
migration and length of stay in Norway for all 25 to 69 years old registered in Norway,
in addition to other socioeconomic variables (age, education, income level, work status,
cluster area for those in intervention and control areas, geographical centrality, civil
status, husbands' immigrant background and GP's immigrant background) that will be used
to adjust our results, and to two variables from the GP database (GP's age and gender)
to identify the GPs in the intervention and control groups in the Health professional
strategy. Data will be linked by Statistics Norway before being accessible to the
researchers. However, since ethnicity is considered sensitive data, and in order to make
the dataset completely anonymous for the research group, we will only apply for the
following groups with regard to country of origin (see page 1 for approximate numbers):
Norway, Western Europe, Eastern Europe, Middle-East, South-East, South Asia, Africa,
North America, Central and South America, Poland, Sweden, Pakistan and Somalia. As
explained below, data will be obtained for several years (2012-2018) in order to be able
to distinguish secular trends in attendance to cervical screening versus the effect due
to our intervention. Data will be stored in a secure server at the University of Bergen
(BIOS, Core Facility for Biostatistics and Data Analyses) in an anonymised form.
2. In addition, the process of how communities and individuals change their behaviour will
be studied using a qualitative approach to the intervention groups after the
interventions. These data will do not include any information that can lead to personal
identification of the women.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06223308 -
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT03367871 -
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04537156 -
Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 3 | |
Recruiting |
NCT03668639 -
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04242199 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
|
Phase 1 | |
Withdrawn |
NCT04806945 -
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
|
Phase 3 | |
Active, not recruiting |
NCT04185389 -
Long-Term Follow-Up of HPV FOCAL Participants
|
||
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
Recruiting |
NCT05107674 -
A Study of NX-1607 in Adults With Advanced Malignancies
|
Phase 1 | |
Completed |
NCT05120167 -
Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy
|
N/A | |
Recruiting |
NCT05483491 -
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
|
Phase 1 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Completed |
NCT05862844 -
Promise Women Project
|
N/A | |
Recruiting |
NCT04934982 -
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
|
N/A | |
Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
Completed |
NCT00543543 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
|
Phase 3 | |
Terminated |
NCT04864782 -
QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
|
Phase 2/Phase 3 | |
Recruiting |
NCT04226313 -
Self-sampling for Non-attenders to Cervical Cancer Screening
|
N/A |